BioHarvest Sciences has completed development and commercial-scale manufacturing readiness for its proprietary Olive Cell composition, derived from olive fruit cells and rich in Verbascoside. This milestone includes successful scale-up, self-affirmed GRAS status, and readiness for production at BioHarvest's GMP facility. The Olive Cell shows promising preclinical activity related to liver health and potential applications in nutraceuticals, cosmetics, and wellness. BioHarvest plans to license and commercialize this asset through its CDMO business, expanding its portfolio of proprietary plant-derived compounds.
BioHarvest's Olive Cell asset development is the subject here. For readers following the Health sector, here is Pluang's market snapshot as of Oct 13, 2026 16:51 WIB: of 128 priced US Health-sector stocks, 80 rose and 41 fell. Notable movers include SNY at USD 40.52 (+1.96%), TLRY at USD 3.30 (-1.79%), and INCY at USD 109.38 (-1.78%).
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...
Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...
BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...
